Prostacyclin analogues

the next drug-eluting stent?

C. McCormick, R. M. Wadsworth, R. L. Jones, S. Kennedy

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Recent concern over existing drug-eluting stents, for the treatment of myocardial ischaemia, has led to the development of approaches that seek to inhibit restenosis while promoting the recovery of a functional endothelium. Prostacyclin analogues may be worthy candidates for use within a drug-eluting stent by virtue of their wide profile of vasoprotective effects. This article reviews recent developments in this area, and in so doing, reveals the future challenges for the further development of this technology.

Original languageEnglish
Pages (from-to)910-911
Number of pages2
JournalBiochemical Society Transactions
Volume35
Issue numberPart 5
DOIs
Publication statusPublished - Nov 2007
EventFocus Topic at Life Sciences 2007 Conference - Glasgow, United Kingdom
Duration: 9 Jul 200712 Jul 2007

Fingerprint

Drug-Eluting Stents
Stents
Epoprostenol
Pharmaceutical Preparations
Endothelium
Myocardial Ischemia
Technology
Recovery

Keywords

  • drug-eluting stent
  • human coronary artery
  • prostacyclin
  • prostanoid receptor
  • restenosis
  • smooth muscle cell proliferation
  • neointima formation
  • coronary-arteries
  • coated stents
  • iloprost
  • pib
  • proliferation
  • receptors
  • cells

Cite this

McCormick, C. ; Wadsworth, R. M. ; Jones, R. L. ; Kennedy, S. / Prostacyclin analogues : the next drug-eluting stent?. In: Biochemical Society Transactions. 2007 ; Vol. 35, No. Part 5. pp. 910-911.
@article{648eb5b1abdd4628b3560a450d0977e4,
title = "Prostacyclin analogues: the next drug-eluting stent?",
abstract = "Recent concern over existing drug-eluting stents, for the treatment of myocardial ischaemia, has led to the development of approaches that seek to inhibit restenosis while promoting the recovery of a functional endothelium. Prostacyclin analogues may be worthy candidates for use within a drug-eluting stent by virtue of their wide profile of vasoprotective effects. This article reviews recent developments in this area, and in so doing, reveals the future challenges for the further development of this technology.",
keywords = "drug-eluting stent, human coronary artery, prostacyclin, prostanoid receptor, restenosis, smooth muscle cell proliferation, neointima formation, coronary-arteries, coated stents, iloprost, pib, proliferation, receptors, cells",
author = "C. McCormick and Wadsworth, {R. M.} and Jones, {R. L.} and S. Kennedy",
year = "2007",
month = "11",
doi = "10.1042/BST0350910",
language = "English",
volume = "35",
pages = "910--911",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
number = "Part 5",

}

Prostacyclin analogues : the next drug-eluting stent? / McCormick, C.; Wadsworth, R. M.; Jones, R. L.; Kennedy, S.

In: Biochemical Society Transactions, Vol. 35, No. Part 5, 11.2007, p. 910-911.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prostacyclin analogues

T2 - the next drug-eluting stent?

AU - McCormick, C.

AU - Wadsworth, R. M.

AU - Jones, R. L.

AU - Kennedy, S.

PY - 2007/11

Y1 - 2007/11

N2 - Recent concern over existing drug-eluting stents, for the treatment of myocardial ischaemia, has led to the development of approaches that seek to inhibit restenosis while promoting the recovery of a functional endothelium. Prostacyclin analogues may be worthy candidates for use within a drug-eluting stent by virtue of their wide profile of vasoprotective effects. This article reviews recent developments in this area, and in so doing, reveals the future challenges for the further development of this technology.

AB - Recent concern over existing drug-eluting stents, for the treatment of myocardial ischaemia, has led to the development of approaches that seek to inhibit restenosis while promoting the recovery of a functional endothelium. Prostacyclin analogues may be worthy candidates for use within a drug-eluting stent by virtue of their wide profile of vasoprotective effects. This article reviews recent developments in this area, and in so doing, reveals the future challenges for the further development of this technology.

KW - drug-eluting stent

KW - human coronary artery

KW - prostacyclin

KW - prostanoid receptor

KW - restenosis

KW - smooth muscle cell proliferation

KW - neointima formation

KW - coronary-arteries

KW - coated stents

KW - iloprost

KW - pib

KW - proliferation

KW - receptors

KW - cells

UR - http://www.biochemsoctrans.org/content/35/5/910

U2 - 10.1042/BST0350910

DO - 10.1042/BST0350910

M3 - Article

VL - 35

SP - 910

EP - 911

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - Part 5

ER -